Long-term voriconazole and skin cancer: Is there cause for concern?

Current Infectious Disease Reports

Volumn 13, Issue 6, 2011, Pages 536-543

  Clancy, Cornelius J ^a,b   Nguyen, M Hong ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Skin cancer; Squamous cell; Toxicity; Voriconazole

Indexed keywords

VORICONAZOLE;

ACTINIC KERATOSIS; CANCER DIAGNOSIS; CANCER RISK; CAUSAL ATTRIBUTION; CHRONIC DRUG ADMINISTRATION; COCCIDIOIDOMYCOSIS; DIARRHEA; DISEASE ASSOCIATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG METABOLISM; ERYTHEMA; EXFOLIATIVE DERMATITIS; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; INFECTION PREVENTION; LENTIGINOSIS; MENINGITIS; MYCOSIS; NAUSEA; NERVOUS SYSTEM MALFORMATION; NONHUMAN; PHOTOAGING; PHOTOSENSITIVITY; PSEUDOPORPHYRIA; REVIEW; RISK ASSESSMENT; RISK FACTOR; SKIN CANCER; SKIN DEFECT; SQUAMOUS CELL CARCINOMA; TELANGIECTASIA; TREATMENT DURATION; VISUAL DISORDER; VOMITING;

EID: 81155151460     PISSN: 15233847     EISSN: 15343146     Source Type: Journal    
DOI: 10.1007/s11908-011-0220-x     Document Type: Review

References (42)

1. TJ Walsh I Lutsar T Driscoll, et al. 2002 Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children Pediatr Infect Dis J. 21 240 248 12005089 10.1097/00006454-200203000- 00015 (Pubitemid 34214142)
2. LB Johnson CA Kauffman 2003 Voriconazole: a new triazole antifungal agent Clin Infect Dis. 36 630 637 12594645 10.1086/367933 1:CAS:528: DC%2BD3sXisFals7s%3D (Pubitemid 36259570)
3. T Hilliard S Edwards R Buchdahl, et al. 2005 Voriconazole therapy in children with cystic fibrosis J Cyst Fibros. 4 215 220 16243008 10.1016/j.jcf.2005.05.019 1:CAS:528:DC%2BD2MXht1OlsbbK (Pubitemid 43013027)
4. R Herbrecht DW Denning TF Patterson, et al. 2002 Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis N Engl J Med. 347 408 415 12167683 10.1056/NEJMoa020191 1:CAS:528:DC%2BD38XlvFKrt7o%3D (Pubitemid 34851833)
5. KJ Cortez TJ Walsh JE Bennett 2003 Successful treatment of coccidioidal meningitis with voriconazole Clin Infect Dis. 36 1619 1622 12802765 10.1086/375235 1:CAS:528:DC%2BD3sXlslyrtrs%3D (Pubitemid 36783349)
6. D Przepiorka FK Buadi B McClune 2008 Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia Pharmacotherapy. 28 58 63 18154475 10.1592/phco.28.1.58 1:CAS:528: DC%2BD1cXhtlehu7g%3D
7. A Vadnerkar MH Nguyen D Mitsani, et al. 2010 Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients J Heart Lung Transplant. 29 1240 1244 20591690 10.1016/j.healun.2010.05.022 A case-control study of lung transplant recipients receiving alemtuzumab induction, which identified the duration of voriconazole therapy as an independent risk factor fo cutaneous squamous cell carcinoma.
8. JR Wingard SL Carter TJ Walsh, et al. 2010 Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation Blood. 116 5111 5118 20826719 10.1182/blood-2010-02-268151 1:CAS:528:DC%2BC3MXotFU%3D
9. I Amigues N Cohen D Chung, et al. 2010 Hepatic safety of voriconazole after allogeneic hematopoietic stem cell transplantation Biol Blood Marrow Transplant. 16 46 52 20053331 10.1016/j.bbmt.2009.08.015 1:CAS:528: DC%2BC3cXhvFWrtLY%3D
10. DD Miller EW Cowen JC Nguyen, et al. 2010 Melanoma associated with long-term voriconazole therapy: a new manifestation of chronic photosensitivity Arch Dermatol. 146 300 304 20083676 10.1001/archdermatol.2009.362 1:CAS:528:DC%2BC3cXks1Sqt70%3D The first report of melanoma among patients receiving long-term voriconazole
11. DW Denning CE Griffiths 2001 Muco-cutaneous retinoid-effects and facial erythema related to the novel triazole antifungal agent voriconazole Clin Exp Dermatol. 26 648 653 11722447 10.1046/j.1365-2230.2001.00909.x 1:STN:280:DC%2BD3Mnns1yitg%3D%3D (Pubitemid 33070418)
12. JP Tolland PP McKeown JR Corbett 2007 Voriconazole-induced pseudoporphyria Photodermatol Photoimmunol Photomed. 23 29 31 17254033 10.1111/j.1600-0781.2007.00263.x 1:STN:280:DC%2BD2s%2FltVaisA%3D%3D (Pubitemid 46189304)
13. CK Dolan MA Hall DL Blazes CW Norwood 2004 Pseudoporphyria as a result of voriconazole use: a case report Int J Dermatol. 43 768 771 15485539 10.1111/j.1365-4632.2004.02177.x (Pubitemid 39405866)
14. AJ Racette HH Roenigk Jr R Hansen, et al. 2005 Photoaging and phototoxicity from long-term voriconazole treatment in a 15-year-old girl J Am Acad Dermatol. 52 S81 S85 15858516 10.1016/j.jaad.2004.07.034
15. JP Van Wauwe MC Coene J Goossens, et al. 1990 Effects of cytochrome P-450 inhibitors on the in vivo metabolism of all-trans-retinoic acid in rats J Pharmacol Exp Ther. 252 365 369 2299598 (Pubitemid 20067737)
16. N Auffret F Janssen P Chevalier, et al. 2006 Voriconazole photosensitivity: 7 cases Ann Dermatol Venereol. 133 330 332 16733446 10.1016/S0151-9638(06)70910-3 1:STN:280:DC%2BD28zgsV2qsA%3D%3D (Pubitemid 43844223)
17. M Rubenstein ML Levy D Metry 2004 Voriconazole-induced retinoid-like photosensitivity in children Pediatr Dermatol. 21 675 678 15575856 10.1111/j.0736-8046.2004.21614.x (Pubitemid 39657395)
18. KH Kraemer JJ DiGiovanna AN Moshell, et al. 1988 Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin N Engl J Med. 318 1633 1637 3287161 10.1056/NEJM198806233182501 1:STN:280:DyaL1c3jt1yhtA%3D%3D
19. JN Bavinck LM Tieben FJ Van der Woude, et al. 1995 Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study J Clin Oncol. 13 1933 1938 7636533 1:STN:280:DyaK2MzmtlCktw%3D%3D
20. EW Cowen JC Nguyen DD Miller, et al. 2010 Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole J Am Acad Dermatol. 62 31 37 19896749 10.1016/j.jaad.2009.09.033 1:CAS:528:DC%2BC3cXht1ans78%3D Case series of 8 patients, which includes good discussions on voriconazole-associated phototoxicity and links between ultraviolet exposure and skin cancer
21. N Murayama N Imai T Nakane, et al. 2007 Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes Biochem Pharmacol. 73 2020 2026 17433262 10.1016/j.bcp.2007.03.012 1:CAS:528:DC%2BD2sXkvFOjurY%3D (Pubitemid 46677908)
22. SJ Roffey S Cole P Comby, et al. 2003 The disposition of voriconazole in mouse, rat, rabbit, guinea pig, dog, and human Drug Metab Dispos. 31 731 741 12756205 10.1124/dmd.31.6.731 1:CAS:528:DC%2BD3sXkt1KrtLw%3D (Pubitemid 36617661)
23. D Grossman DJ Leffell 1997 The molecular basis of nonmelanoma skin cancer: new understanding Arch Dermatol. 133 1263 1270 9382565 10.1001/archderm.133.10.1263 1:CAS:528:DyaK2sXntVGksbk%3D (Pubitemid 27443819)
24. GM Halliday JG Lyons 2008 Inflammatory doses of UV may not be necessary for skin carcinogenesis Photochem Photobiol. 84 272 283 18353168 10.1111/j.1751-1097.2007.00247.x 1:CAS:528:DC%2BD1cXjt1Cruro%3D (Pubitemid 351421380)
25. KL McCarthy EG Playford DF Looke M Whitby 2007 Severe photosensitivity causing multifocal squamous cell carcinomas secondary to prolonged voriconazole therapy Clin Infect Dis. 44 e55 e56 17278050 10.1086/511685 1:CAS:528: DC%2BD2sXivVOhsrw%3D An early report of a patient from Australia with chronic granulomatous disease
26. A Vanacker G Fabre J Van Dorpe, et al. 2008 Aggressive cutaneous squamous cell carcinoma associated with prolonged voriconazole therapy in a renal transplant patient Am J Transplant. 8 877 880 18261173 10.1111/j.1600-6143.2007. 02140.x 1:STN:280:DC%2BD1c7msV2rsQ%3D%3D Case report of a patient with polyarteritis nodosa and subsequent renal transplant, which highlights the aggressive nature of cutaneous squamous cell carcinoma in many patients receiving voriconazole (Pubitemid 351347751)
27. J Smith N Safdar V Knasinski, et al. 2006 Voriconazole therapeutic drug monitoring Antimicrob Agents Chemother. 50 1570 1572 16569888 10.1128/AAC.50.4.1570-1572.2006 1:CAS:528:DC%2BD28XjvFOrtrg%3D
28. RJ Bruggemann JW Alffenaar NM Blijlevens, et al. 2009 Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents Clin Infect Dis. 48 1441 1458 19361301 10.1086/598327
29. O Epaulard C Saint-Raymond C Villier, et al. 2010 Multiple aggressive squamous cell carcinomas associated with prolonged voriconazole therapy in four immunocompromised patients Clin Microbiol Infect. 16 1362 1364 19930272 10.1111/j.1469-0691.2009.03124.x 1:STN:280:DC%2BC3MvjsFaltw%3D%3D Case series of 3 lung transplant recipients and one patient with lung cancer, which reported regression of lesions after stopping voriconazole
30. SF Ibrahim JP Singer ST Arron 2010 Catastrophic squamous cell carcinoma in lung transplant patients treated with voriconazole Dermatol Surg. 36 1752 1755 20533939 10.1111/j.1524-4725.2010.01596.x 1:CAS:528:DC%2BC3cXhsVamsrrM Reports of two patients, which highlights the poor outcomes due to cutaneous squamous cell carcinoma in this population
31. AS Brunel T Fraisse C Lechiche, et al. 2008 Multifocal squamous cell carcinomas in an HIV-infected patient with a long-term voriconazole therapy AIDS. 22 905 906 18427212 10.1097/QAD.0b013e3282f706a9 A detailed case report of a person with AIDS and Kaposi sarcoma who developed multifocal cutaneous squamous cell carcinoma (Pubitemid 351563843)
32. MC Webb F Compton PA Andrews CG Koffman 1997 Skin tumours posttransplantation: a retrospective analysis of 28 years' experience at a single centre Transplant Proc. 29 828 830 9123544 10.1016/S0041-1345(96)00152-2 1:STN:280:DyaK2s3jt1GqtA%3D%3D (Pubitemid 27125980)
33. JT Winkelhorst WJ Brokelman RG Tiggeler T Wobbes 2001 Incidence and clinical course of de-novo malignancies in renal allograft recipients Eur J Surg Oncol. 27 409 413 11417989 10.1053/ejso.2001.1119 1:STN:280: DC%2BD3MzlslGrtA%3D%3D (Pubitemid 32624545)
34. EQ Sanchez S Marubashi G Jung, et al. 2002 De novo tumors after liver transplantation: a single-institution experience Liver Transpl. 8 285 291 11910575 10.1053/jlts.2002.29350 (Pubitemid 34257212)
35. S Euvrard AC Butnaru 2004 Skin cancer risk after organ transplantation Pathol Biol (Paris). 52 160 163 1:STN:280:DC%2BD2c3jsFGmtg%3D%3D (Pubitemid 38456720)
36. AB Fortina AL Caforio S Piaserico, et al. 2000 Skin cancer in heart transplant recipients: frequency and risk factor analysis J Heart Lung Transplant. 19 249 255 10713249 10.1016/S1053-2498(99)00137-0 1:STN:280:DC%2BD3c7nvFCmsw%3D%3D (Pubitemid 30122387)
37. P Jensen B Moller S Hansen 2000 Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens J Am Acad Dermatol. 42 307 10642700 1:STN:280:DC%2BD3c7htFahsA%3D%3D (Pubitemid 30469641)
38. P Jensen S Hansen B Moller, et al. 1999 Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens J Am Acad Dermatol. 40 177 186 10025742 10.1016/S0190-9622(99)70185-4 1:STN:280:DyaK1M7kvVKjuw%3D%3D (Pubitemid 29072794)
39. MJ Fuente M Sabat J Roca, et al. 2003 A prospective study of the incidence of skin cancer and its risk factors in a Spanish Mediterranean population of kidney transplant recipients Br J Dermatol. 149 1221 1226 14674900 10.1111/j.1365-2133.2003.05740.x 1:STN:280:DC%2BD3srptlyksA%3D%3D (Pubitemid 38058098)
40. EP Trulock LB Edwards DO Taylor, et al. 2004 The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult lung and heart-lung transplant report-2004 J Heart Lung Transplant. 23 804 815 15285066 10.1016/j.healun.2004.05.013 (Pubitemid 38953863)
41. JN Bouwesbavinck DR Hardie A Green, et al. 1996 The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study Transplantation. 61 715 721 10.1097/00007890-199603150-00008 1:STN:280:DyaK287nvFSntw%3D%3D (Pubitemid 26097231)
42. S Euvrard J Kanitakis C Pouteil-Noble, et al. 1995 Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation J Am Acad Dermatol. 33 222 229 7622649 10.1016/0190-9622(95)90239-2 1:STN:280:DyaK2MzkvVaqsg%3D%3D